Icon profits down $500,000

ISEQ-listed clinical research group Icon has reported 2004 second quarter net profits of $5.8m (€4.4m), compared with $6.3m (€4.8m) in the same quarter in 2003.

Revenues were up 9% at $79.5%, 6% when the impact of acquisitions is stripped out.